Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy; D001379:Azathioprine / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000628:therapy*; D003348:Cortisone / Q000627:therapeutic use*; D004322:Drainage; D004660:Encephalitis / Q000188:drug therapy / Q000628:therapy; D004679:Encephalomyelitis / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D008196:Lymph; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000628:therapy; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000628:therapy; D009879:Ophthalmia, Sympathetic / Q000188:drug therapy / Q000628:therapy; D013897:Thoracic Duct; D013997:Time Factors
D000961:Antilymphocyte Serum; D001379:Azathioprine; D003348:Cortisone